Atlas Trials

Factors Determining the Prognosis in NSCLC Stage IV

Clinical trial NCT04306094 · UNKNOWN

Trial details

NCT number
NCT04306094
Sponsor
Instituto do Cancer do Estado de São Paulo
Status
UNKNOWN
Study type
OBSERVATIONAL
NSCLC Stage IV
Start date
2017-11-01
Primary completion
2021-12-31
Enrollment
217

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.